Varied actions of proinflammatory cytokines on excitotoxic cell death in the rat central nervous system

Journal of Neuroscience Research

Volumn 67, Issue 4, 2002, Pages 428-434

  Allan, Stuart M ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Excitotoxicity; Interleukin 1; Interleukin 6; Neurodegeneration; Tumor necrosis factor

Indexed keywords

ALPHA AMINO 3 HYDROXY 5 METHYL 4 ISOXAZOLEPROPIONIC ACID; CYTOKINE; EXCITOTOXIN; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DEATH; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; CORPUS STRIATUM; CYTOTOXICITY; DEGENERATIVE DISEASE; INFLAMMATION; MALE; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RAT;

ALPHA-AMINO-3-HYDROXY-5-METHYL-4-ISOXAZOLEPROPIONIC ACID; ANIMALS; CELL DEATH; CENTRAL NERVOUS SYSTEM; CEREBRAL CORTEX; CYTOKINES; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; ENCEPHALITIS; EXCITATORY AMINO ACID AGONISTS; INTERLEUKIN-1; INTERLEUKIN-6; MALE; NEOSTRIATUM; NERVE DEGENERATION; NEURONS; NEUROTOXINS; RATS; RATS, SPRAGUE-DAWLEY; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0037083191     PISSN: 03604012     EISSN: None     Source Type: Journal    
DOI: 10.1002/jnr.10142     Document Type: Article

References (45)

1. Cortical death caused by striatal administration of AMPA and interleukin-1 is mediated by activation of cortical NMDA receptors
2. Cytokines and acute neurodegeneration
3. Cortical cell death induced by interleukin-1 is mediated via actions in the hypothalamus of the rat
4. Biological activity and brain actions of recombinant rat interleukin-1alpha and interleukin-1beta
5. Tumor necrosis factor-a: A mediator of focal ischemic brain injury
6. Limbic seizure and brain damage produced by kainic acid: Mechanisms and relevance to human temporal lobe epilepsy
7. Attenuation of stroke size in rats using an adenoviral vector to induce over expression of interleukin-1 receptor antagonist in brain
8. Role of IL-1alpha and IL-1beta in ischemic brain damage
9. Altered neuronal and microglial responses to excitotoxic and ischemic brain injury in mice lacking TNF receptors
10. Neurologic disease induced in transgenic mice by cerebral overexpression of interleukin 6
11. Inhibition of tumor necrosis factor-alpha reduces focal cerebral ischemic injury in the spontaneously hypertensive rat
12. Blocking IL-1: Interleukin-1 receptor antagonist in vivo and in vitro
13. Pharmacological modification of glutamate neurotoxicity in vivo
14. The transcription factor NF-kB mediates increases in calcium currents and decreases in NMDA- and AMPA/kainate-induced currents induced by tumor necrosis factor-a in hippocampal neurons
15. Expression of interleukin-6 (IL-6) and interleukin-6 receptor (IL-6R) mRNAs in rat brain during postnatal development
16. Neurotoxicity of excitatory amino acid receptor agonists in rat cerebellar slices: Dependence on calcium concentration
17. Glutamate toxicity: An experimental and theoretical analysis
18. Ischemic and excitotoxic brain injury is enhanced in mice lacking the p55 tumor necrosis factor receptor
19. Site of action of IL-1 on AMPA receptor mediated excitotoxicity within the rat striatum
20. Circulating antibody against tumor necrosis factor-alpha protects rat brain from reperfusion injury
21. Interleukin-1beta and the interleukin-1 receptor antagonist act in the striatum to modify excitotoxic brain damage in the rat
22. Neuroprotective effects of human recombinant interleukin-1 receptor antagonist in focal cerebral ischaemia in the rat
23. Cerebral interleukin-6 is neuroprotective during permanent focal cerebral ischemia in the rat
24. Antisense oligodeoxynucleotide inhibition of tumor necrosis factor-alpha expression is neuroprotective after intracerebral hemorrhage
25. Tumor necrosis factor is a brain damaging cytokine in cerebral ischemia
26. Inhibition of tumor necrosis factor and amelioration of brain infarction in mice
27. Neuroprotective effects of TNF binding protein in focal cerebral ischemia
28. TNF-a pretreatment induces protective effects against focal cerebral ischemia in mice
29. Non-NMDA and NMDA receptor-mediated excitotoxic neuronal deaths in adult brain are morphologically distinct: Further evidence for an apotosis-necrosis continuum
30. Rat interleukin-6: Expression in recombinant Escherichia coli, purification and development of a novel ELISA
31. Interleukin-1 receptor antagonist inhibits ischaemic and excitotoxic neuronal damage in the rat
32. Interleukin 1 in the brain: Biology, pathology, and therapeutic target
33. Differential acute and chronic responses of tumor necrosis factor-deficient mice to experimental brain injury
34. The two interleukin-1 receptors play different roles in IL-1 actions
35. The role of TNF-alpha in fever: Opposing actions of human and murine TNF-alpha and interactions with IL-beta in the rat
36. Exacerbation of ischemic brain damage by localized striatal injection of interleukin-1beta in the rat
37. Interleukin-1 receptor antagonist inhibits neuronal damage caused by fluid percussion injury in the rat
38. Local infusion of interleukin-6 attenuates the neurotoxic effects of NMDA on rat striatal cholinergic neurons
39. Tumor necrosis factor a and insulin-like growth factor-I in the brain: Is the whole greater than the sum of its parts
40. Interleukin-1b immunoreactivity and microglia are enhanced in the rat hippocampus by focal kainate application: Functional evidence for enhancement of electrographic seizures
41. Powerful anticonvulsant action of IL-1 receptor antagonist on intracerebral injection and astrocytic overexpression in mice
42. Cytokine signals propagate through the brain
43. Interleukin-1 as a pathogenetic mediator of ischemic brain damage in rats
44. Expression of interleukin (IL)-1b, IL-6 and their respective receptors in the normal rat brain and after injury